Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
SHTDY SINOPHARM GROUP CO
11.830
+0.470+4.14%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(FY)2020/12/31(FY)2019/12/31(FY)2018/12/31
Total revenue
14.16% 521.05B 7.32% 456.41B 23.44% 425.27B 24.36% 344.53B
Operating revenue
14.16% 521.05B 7.32% 456.41B 23.44% 425.27B 24.36% 344.53B
Cost of revenue
14.64% 477B 7.31% 416.09B 23.76% 387.74B 23.04% 313.3B
Gross profit
9.24% 44.05B 7.44% 40.32B 20.18% 37.53B 39.48% 31.23B
Operating expense
10.08% 22.61B 7.94% 20.54B 22.97% 19.03B 38.52% 15.47B
Selling and administrative expenses
9.47% 23.2B 8.85% 21.19B 22.54% 19.47B 37.31% 15.89B
-Selling and marketing expense
9.16% 15.44B 12.62% 14.14B 21.09% 12.56B 40.45% 10.37B
-General and administrative expense
10.09% 7.76B 1.99% 7.05B 25.27% 6.91B 31.78% 5.52B
Operating profit
8.38% 21.44B 6.92% 19.78B 17.45% 18.5B 40.44% 15.75B
Net non-operating interest income expense
-15.58% -3.4B 6.16% -2.94B 23.39% -3.14B -121.89% -4.1B
Non-operating interest income
-17.42% 558.56M 30.21% 676.36M 1.17% 519.44M -49.13% 513.42M
Non-operating interest expense
9.70% 3.76B -0.52% 3.42B -17.19% 3.44B 59.17% 4.16B
Total other finance cost
4.50% 204.6M -8.66% 195.79M -52.51% 214.35M 85.82% 451.39M
Other net income (expense)
Special income (charges)
-14.72% -1.09B -72.73% -948.17M -54.67% -548.93M -200.82% -354.91M
-Less:Restructuring and merger&acquisition
-- -- -- -- -- -- -- 0
-Less:Impairment of capital assets
129.91% 609.5M 45.65% 265.1M -- 182.02M -- --
-Less:Other special charges
22.82% -110.67M -179.32% -143.38M -2,015.99% -51.33M 99.23% -2.43M
-Write off
-28.75% 588.87M 97.60% 826.45M 17.05% 418.25M -- 357.34M
Other non- operating income (expenses)
352.14% 56.41M 2,571.31% 12.48M -86.98% 467K 114.63% 3.59M
Income before tax
9.01% 17B 13.36% 15.6B 12.71% 13.76B 20.00% 12.21B
Income tax
12.50% 3.94B 11.50% 3.5B 12.00% 3.14B 21.63% 2.8B
Net income
8.00% 13.06B 13.91% 12.1B 12.93% 10.62B 19.53% 9.4B
Net income continuous Operations
8.00% 13.06B 13.91% 12.1B 12.93% 10.62B 19.53% 9.4B
Minority interest income
8.07% 5.31B 12.42% 4.91B 22.39% 4.37B 38.05% 3.57B
Net income attributable to the parent company
7.95% 7.76B 14.95% 7.19B 7.14% 6.25B 10.46% 5.84B
Preferred stock dividends
0 0 0 0
Other preferred stock dividends
0 -93.74% 74K -48.50% 1.18M -27.60% 2.3M
Net income attributable to common stockholders
7.95% 7.76B 14.97% 7.19B 7.16% 6.25B 10.49% 5.83B
Basic earnings per share
7.79% 12.45 9.48% 11.55 7.11% 10.55 3.14% 9.85
Diluted earnings per share
7.79% 12.45 10.00% 11.55 7.14% 10.5 2.62% 9.8
Dividend per share
17.19% 3.4845 1.12% 2.9733 1.42% 2.9404 16.88% 2.8993
Currency Unit
CNYCNYCNYCNY

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.
CEO: --
Market: Pink Market
Listing Date: 09/23/2009
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist